Novartis AG - ADR



-9.2% last 12 months

Market Cap

$195 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$79.34 - $95.17

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio


The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$3.20 (4.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $195 Billion
Enterprise Value $221 Billion
Dividend Yield $3.20 (4.0%)
1 Year Return -5.2%
52-Week High $95.17
52-Week Low $79.34
Beta 0.45
Outstanding Shares 2.43 Billion
Avg 30 Day Volume 2.17 Million


P/E Ratio 33.77
PEG -62.69
Earnings per Share $2.54
Price to Sales Ratio 7.27
Price to Book Ratio 3.48
Revenue to Enterprise Value 7.87
EBIT to Enterprise Value 32.87
Total Debt to Enterprise Value 0.16
Debt to Equity 0.6


Revenue $28.1 Billion
Gross Profit $19.1 Billion
EBIT $6.72 Billion
Net Income $5.76 Billion
Profit Margin 20.55%
Quarterly Earnings Growth (YoY) -53.9%
Return on Equity 10.15%
Return on Assets 4.76%
Return on Invested Capital 7.35%

Insider trades

No purchases

No sells

No purchases

No sells

No purchases

No sells

No purchases

No sells

Q1 2021 Q2 2021 Q3 2021 Q4 2021

About Novartis AG - ADR

CEO: Vasant Narasimhan

Industry: Pharmaceuticals: Major

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Similar stocks

Merck & Co Inc
Pfizer Inc.
Johnson & Johnson
Sanofi - ADR
Glaxosmithkline plc - ADR
Teva- Pharmaceutical Industries Ltd. - ADR
Abbott Laboratories
Bayer AG - ADR
Astrazeneca plc - ADR